Ulland Investment Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$123K Hold
957
0.09% 91
2026
Q1
$115K Hold
957
0.1% 88
2025
Q4
$101K Hold
957
0.08% 90
2025
Q3
$80K Sell
957
-26
-3% -$2.14K 0.06% 101
2025
Q2
$78K Hold
983
0.06% 95
2025
Q1
$88K Hold
983
0.07% 89
2024
Q4
$98K Hold
983
0.06% 85
2024
Q3
$112K Sell
983
-34
-3% -$4.04K 0.08% 73
2024
Q2
$126K Hold
1,017
0.09% 77
2024
Q1
$134K Buy
1,017
+34
+3% +$4.19K 0.11% 74
2023
Q4
$107K Hold
983
0.11% 78
2023
Q3
$101K Hold
983
0.11% 74
2023
Q2
$113K Hold
983
0.12% 72
2023
Q1
$105K Hold
983
0.12% 67
2022
Q4
$109K Hold
983
0.13% 67
2022
Q3
$85K Sell
983
-30
-3% -$2.68K 0.09% 70
2022
Q2
$92K Hold
1,013
0.09% 69
2022
Q1
$83K Buy
1,013
+30
+3% +$2.37K 0.06% 85
2021
Q4
$75K Buy
+983
New +$78.3K 0.05% 92

Other funds holding MRK

Ulland Investment Advisors's MRK Position: Q2 2026 in Review

Ulland Investment Advisors held its Merck (MRK) position steady in Q2 2026 at 957 shares worth $123K. The position accounts for 0.09% of the portfolio, ranked #91.

Ulland Investment Advisors first reported a position in MRK in Q4 2021 and has held it in 19 quarters since. The position peaked at $134K in Q1 2024. 1,533 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Ulland Investment Advisors held 957 shares of Merck worth $123K as of Q2 2026.
  • Ulland Investment Advisors left its Merck share count unchanged in Q2 2026.
  • Merck made up 0.09% of Ulland Investment Advisors's portfolio in Q2 2026, its #91 holding.
  • Ulland Investment Advisors first reported a position in Merck in Q4 2021 and has held it in 19 quarters since.
  • Ulland Investment Advisors's Merck position peaked at $134K in Q1 2024.
  • 1,533 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Ulland Investment Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.